ZLCS Zalicus is a biopharmaceutical focusing on the treatment of pain and inflammation. The company’s clinical candidates for pain and inflammatory diseases include Synavive, which is in Phase 2b clinical development for the treatment of rheumatoid arthritis

Zalicus has a research collaboration and license agreement with the Novartis Institutes of Biomedical Research, Mallinckrodt, Fovea Pharmaceuticals and Amgen Inc; and a cooperative research and development agreement with the United States Army Medical Research Institute. Very Attractive, Bouncing back from 52WK Lows.

GMO- General Moly is a mining company. The company primarily explores for gold, silver, molybdenum, and zinc. Its primary asset includes an 80% interest in the Mt. Hope Project containing proven and probable molybdenum reserves totaling 1.3 billion pounds located in Eureka County, Nevada.

The company also owns 100% interest in the Liberty molybdenum property located in Nevada. In addition, it holds interests in other mining properties located in Oregon, Idaho, and Washington. Attractive, long term.

You are missing the Premium Alerts! Sign-up, Get Alerts that MakeMoney!®

we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks